The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report.
COVID-19
Convalescent plasma
Coronavirus
Pregnancy
Remdesivir
SARS CoV-2
Journal
Case reports in women's health
ISSN: 2214-9112
Titre abrégé: Case Rep Womens Health
Pays: Netherlands
ID NLM: 101682122
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
12
05
2020
accepted:
14
05
2020
pubmed:
20
5
2020
medline:
20
5
2020
entrez:
20
5
2020
Statut:
epublish
Résumé
Remdesivir is a novel therapeutic with known activity against SARS CoV-2 and related coronaviruses. Remdesivir, as well as convalescent plasma therapy, are currently under investigation as potential therapies for patients with Coronavirus Disease 19 (COVID-19). In this case report we summarize the use of convalescent plasma therapy and then remdesivir as a late addition in the treatment of a critically ill obstetric patient with COVID-19. The patient subsequently improved, was extubated 5 days after initiation of remdesivir, was transitioned to room air 24 h later, and discharged at the completion of remdesivir therapy.
Identifiants
pubmed: 32426243
doi: 10.1016/j.crwh.2020.e00221
pii: S2214-9112(20)30051-5
pii: e00221
pmc: PMC7229947
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e00221Informations de copyright
© 2020 The Authors.
Références
Am J Obstet Gynecol. 2020 Jun;222(6):521-531
pubmed: 32217113
Toxicol Appl Pharmacol. 1980 Jan;52(1):99-112
pubmed: 7361317
JAMA. 2020 Apr 28;323(16):1582-1589
pubmed: 32219428
Nat Rev Immunol. 2005 Dec;5(12):917-27
pubmed: 16322745
Clin Immunol. 2020 Jun;215:108448
pubmed: 32353634
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
N Engl J Med. 2020 Jun 11;382(24):2327-2336
pubmed: 32275812
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
Viruses. 2019 Apr 04;11(4):
pubmed: 30987343
J Biol Chem. 2020 Apr 10;295(15):4773-4779
pubmed: 32094225
Nat Rev Rheumatol. 2017 Apr;13(4):234-243
pubmed: 28250461
Lancet Infect Dis. 2020 Apr;20(4):398-400
pubmed: 32113510